Viewing Study NCT00967369


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-05-28 @ 5:31 AM
Study NCT ID: NCT00967369
Status: COMPLETED
Last Update Posted: 2020-04-20
First Post: 2009-08-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Classic Hodgkin Lymphoma View
None Refractory Classic Hodgkin Lymphoma View
Keywords: